Needham & Company Starts Immuneering Corporation (IMRX) at Buy; Sees Over 200% Upside
Tweet Send to a Friend
(Updated - December 1, 2023 7:17 AM EST)
Needham & Company analyst Ami Fadia initiates coverage on Immuneering Corporation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham & Company analyst Ami Fadia initiates coverage on Immuneering Corporation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
